Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
(Sharecast News) - GlaxoSmithKline said on Wednesday that it has fired Moncef Slaoui as chair of the board of directors of Galvani, in which it owns a majority stake, amid allegations of sexual harassment.
Read more
* GSK says allegations of harassment have been substantiated* Slaoui was former chief adviser of U.S. Operation Warp Speed* Contract as chairman at Galvani joint venture terminated (Adds Slaoui response)By Ludwig BurgerFRANKFURT, March 24 (Reuters)...
Read more* GSK says allegations of harassment have been substantiated* Slaoui was former chief adviser of U.S. Operation Warp Speed* Contract as chairman at Galvani joint venture terminated (Adds detail on Slaoui's recent work and appointments)By Ludwig Bur...
Read more(Adding details from letter to staff and background)By Ludwig BurgerFRANKFURT, March 24 (Reuters) - GlaxoSmithKline has dismissed Moncef Slaoui, former U.S. government vaccine chief, as chairman of a company controlled by the British drugmaker aft...
Read more(Adds GSK statement)FRANKFURT, March 24 (Reuters) - Glaxosmithkline has dismissed former U.S. vaccine chief Moncef Slaoui as chairman of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed a...
Read more(Adding detail throughout)By Ludwig BurgerFRANKFURT, March 24 (Reuters) - GlaxoSmithKline has dismissed Moncef Slaoui, former U.S. government vaccine chief, as chairman of a company controlled by the British drugmaker after an internal investigati...
Read moreFRANKFURT, March 24 (Reuters) - Glaxosmithkline said that Moncef Slaoui has been dismissed as chairman of Galvani Bioelectronics, which is majority owned by GSK.GSK said the termination of Slaoui's contract was with immediate effect. Slaoui was no...
Read more
Indivior revamps board after accord with biggest shareholder Scopia
Read more(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Read more(Sharecast News) - The Financial Mail on Sunday's Midas column recommended shares of BBGI to its readers, calling attention to management's good track record and the firm's "rich" pipeline of potential investments.
Read moreGlaxoSmithKline begins phase three study for severe asthma treatment
Read more(Sharecast News) - Pharmaceutical giant GlaxoSmithKline said on Tuesday that it has started Phase 3 clinical testing of Medicago's plant-derived Covid-19 vaccine candidate in combination with its own pandemic adjuvant.
Read moreTOP NEWS: GSK and Medicago progress Covid vaccine to phase three study
Read moreLONDON, March 12 (Reuters) - The United Kingdom has recorded a further 175 deaths from people who had tested positive for COVID-19 within 28 days, and 6,609 new cases, official data showed on Friday.The number of deaths was down from the 181 recor...
Read moreSainsbury's names former Reckitt finance boss Hennah as non-executive
Read more
Last checked at